drugset
drugset / Trial / NCT07591077

SGLT2 Adjunct in T1D

NCT07591077 ↗

Phase 2/3 Completed 86 enrolled Ain Shams University
RandomizedParallel-groupSingle-blindTreatment

Summary

Effect of Sodium-Glucose Cotransporter (SGLT) 2 Inhibitors on Diabetic Nephropathy Progression in Adolescents with Type 1 Diabetes Mellitus

Timeline

Start
2024-11-20
Primary completion
2025-11-20
Completion
2026-02-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Empagliflozin Small molecule 10 mg Oral

Indications

diabetic kidney disease type 1 diabetes mellitus